mesowatch
Advocate Says The Fight To Ban Asbestos In The United States Isn’t Over
divider

Advocate Says The Fight To Ban Asbestos In The United States Isn’t Over

Advocate Says The Fight To Ban Asbestos In The United States Isn’t Over

Michael McGrady

Reading Time: 3 mins

Last Modified: October 22, 2020

Michael McGrady - author

Michael McGrady is a critically acclaimed journalist based in the U.S. state of Colorado. He has an extensive background covering harm reduction and risk minimization topics within the realm of public health. Much of his work focuses on drug legalization and the modernization of recreational drug laws. You can find McGrady’s writing in outlets like Filter Magazine, Inside Sources, The South China Morning Post, and several others across the globe.

More to Read

divider

April 22, 2024

Miami Judge Declares Mistrial in Ovarian Cancer Case filed against J&J talc

>READ

divider

April 8, 2024

Florida Jury Hears Opening Statements Against Johnson & Johnson

>READ

divider

March 18, 2024

Historic Victory: EPA Seals the Fate of Asbestos in America

>READ

divider

February 26, 2024

Healing Heroes: Expanding VA Support for Asbestos-Exposed Veterans

>READ

divider

February 1, 2024

Talc Producer Proposes $862.5M Trust to Settle Cancer Claims

>READ

divider

January 24, 2024

The Cost of Powder: J&J’s $700 Million Leap to Settle Asbestos Cancer Claims

>READ

divider

Want to Contribute Breaking News?

To contribute to our constant feed of relevant legal matters

News & Data

divider

FILTER:

search
divider
Johnson & Johnson’s $6.5B Settlement: Long-Term Effect on Future Claims
Johnson & Johnson’s $6.5B Settlement: Long-Term Effect on Future Claims

Melissa Bill
4 mins read - May 7, 2024

Johnson & Johnson is on the verge of settling more than 50,000 lawsuits alleging that the use of its widely-used talc baby powder led to claimants developing ovarian cancer....

Settlements

Illinois Jury Awards $45M in J&J Baby Powder Case
Illinois Jury Awards $45M in J&J Baby Powder Case

Melissa Bill
3 mins read - May 3, 2024

On Friday, an Illinois court ordered Johnson & Johnson and Kenvue to pay $45 million in a case that involved a family that alleged a link between the relative’s death after...

Settlements

Revolutionizing Mesothelioma Care: New Treatment Era with ADI-PEG20
Revolutionizing Mesothelioma Care: New Treatment Era with ADI-PEG20

Mary Pieper
3 mins read - May 2, 2024

In the ongoing battle against mesothelioma, the introduction of ADI-PEG20 (pegargiminase) marks a significant milestone. This innovative drug, hailed for its novel approach,...

Treatment

© 2024 Mesowatch. All right reserved.